Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

human-derived Enterococcus strain MNC-168

An enteric-coated capsule formulation composed of a live Enterococcus strain derived from the human gut microbiome, with potential immunostimulating and antineoplastic activities. Upon administration of the human-derived Enterococcus strain MNC-168, the bacteria may activate the immune system through various mechanisms, including, but not limited to, the recruitment of tumor-infiltrating lymphocytes (TILs) and cytotoxic CD4+ and CD8+ T cells in the tumor microenvironment (TME). This may enhance anti-tumor immune responses and may eradicate tumor cells.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:human-derived live biotherapeutic product MNC-168
live bacterium MNC-168
Code name:MNC 168
MNC-168
MNC168
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search